Current Methods and Research Progress in Nanomaterials Risk Assessment

E-ISSN： 1875-5453|13|4|354-363

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.13, Iss.4, 2012-05, pp. : 354-363

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current Progress in the Genetic Research of Schizophrenia: Relevance for Drug Discovery?

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 8, 2012-06 ,pp. : 1614-1621

Bentham Science Publishers

Access to resources Recommend Favorite

Research Needs for Environmental Health Risk Assessment

By Aitio Antero

Journal of Toxicology and Environmental Health, Vol. 71, Iss. 18, 2008-01 ,pp. : 1254-1258

Taylor & Francis Ltd

Access to resources Recommend Favorite

Accounting for susceptibility in risk assessment: current practice and new directions

By Kimmel C.A. Neumann D.A.

Environmental Toxicology and Pharmacology, Vol. 4, Iss. 3, 1997-12 ,pp. : 189-194

Elsevier

Access to resources Recommend Favorite

Prulifloxacin: in vitro (HERG current) and in vivo (conscious dog) assessment of cardiac risk

By Lacroix P. Crumb W.J. Durando L. Ciottoli G.B.

European Journal of Pharmacology, Vol. 477, Iss. 1, 2003-09 ,pp. : 69-72

Elsevier

Access to resources Recommend Favorite

Inflammatory Biomarkers and Cardiovascular Risk Assessment. Current Knowledge and Future Perspectives

Current Pharmaceutical Design, Vol. 19, Iss. 21, 2013-06 ,pp. : 3827-3840

Bentham Science Publishers

Access to resources Recommend Favorite